Ginkgo Bioworks DNA Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's other noncash income (expense)?
- Ginkgo Bioworks (DNA) reported other noncash income (expense) of -$185K in Q1 2026.
- How has Ginkgo Bioworks's other noncash income (expense) changed year-over-year?
- Ginkgo Bioworks's other noncash income (expense) decreased by 24.2% year-over-year, from -$149K to -$185K.
- What is the long-term trend for Ginkgo Bioworks's other noncash income (expense)?
- Over 2 years (2021 to 2025), Ginkgo Bioworks's other noncash income (expense) has grown at a 870.7% compound annual growth rate (CAGR), from -$23K to -$2.17M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.